EHE 360 Connect

Dr. Scott M. Schuetze, University of Michigan, Rogel Cancer Center, will provide an overview of the rationale for treatment of EHE with trametinib, an oral inhibitor of the MEK kinase; the trial design of 10015/SARC033; and the results of the primary and secondary study endpoints. The presentation will also include an update on exploratory investigation […]

Join us for EHE 360 Connect on Wednesday, January 22, 2025, 12:00-1:00 pm ET. This webinar features Dr. Silvia Stacchiotti, Medical Oncologist at the Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, presenting “Sirolimus for the Treatment of EHE.” In this session, Dr. Stacchiotti will highlight data currently available on the use of Sirolimus to […]

Join us for EHE 360 Connect on Wednesday, July 24, 2024, 5-6 pm ET. This webinar features Greg Cote, MD, PhD, medical oncologist, and early-stage clinical trialist from Mass General Cancer Center presenting “Clinical Trials for EHE.” In this session, Dr. Cote will provide an in-depth look at the drug development process and discuss the […]